Tech Company M&A Transactions
NxThera Acquisition
On 3/22/2018, NxThera was bought by Boston Scientific. Boston Scientific said the transaction price was $406 million.
Transaction Overview
Company Name
Acquired By
Announced On
3/22/2018
Transaction Type
M&A
Amount
$406,000,000
M&A Terms
The transaction consists of an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments over the next four years.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Lane N 138
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Paulson
Chief Financial Officer
Carmen Bringgold
Chief Marketing Officer
Michael Kujak
Chief Operating Officer
Maximillian Fiore
Chief Technical Officer
Michael Hoey
VP - Engineering
Tim Byland
VP - Product Management
Mona Dahdah
Browse more venture capital transactions:
Prev: 3/22/2018: Umuse venture capital transaction
Next: 3/22/2018: Vangst venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs